Friday, March 11, 2022 3:01:36 PM
I'm all fairness to the kon man, those might have been the bankrupt otc companies he bought prior to relisting them as his biotechs. He might have never actually ran them. Make sense?
Btw, is Elizabeth Holmes respectable? Ken Lay or Jeffrey Skilling of Enron?
Bill "I'm friends with Epstein" Gates?
Sam Waskal?
Richard Sackler of Purdue Pharma?
When it comes to investing, it's about competency in running a company.
Koos is anything but competent. He can provide for himself using the the benefits of running a public company but he's never truly delivered much, if anything, to his shareholders.
Btw, is Elizabeth Holmes respectable? Ken Lay or Jeffrey Skilling of Enron?
Bill "I'm friends with Epstein" Gates?
Sam Waskal?
Richard Sackler of Purdue Pharma?
When it comes to investing, it's about competency in running a company.
Koos is anything but competent. He can provide for himself using the the benefits of running a public company but he's never truly delivered much, if anything, to his shareholders.
FACTS are stubborn things
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
